Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Andrew Kazibwe"'
Autor:
Joseph Baruch Baluku, Robinah Nalwanga, Andrew Kazibwe, Ronald Olum, Edwin Nuwagira, Nathan Mugenyi, Frank Mulindwa, Felix Bongomin
Publikováno v:
Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background Active tuberculosis (TB) significantly increases the risk of cardiovascular disease, but the underlying mechanisms remain unclear. This study aimed to investigate the association between inflammation biomarkers and dyslipidemia in
Externí odkaz:
https://doaj.org/article/adff972c88f54b58b0271e5fc06088ed
Autor:
Vianney John Kigongo, Joaniter I. Nankabirwa, Freddy Eric Kitutu, Ronald Ssenyonga, Ronald Kasoma Mutebi, Andrew Kazibwe, Ronald Kiguba, Andrew D. Kambugu, Barbara Castelnuovo
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Understanding the burden of dyslipidemia and its associated factors among adult people living with HIV on dolutegravir (DTG) based anti-retroviral therapy (ART) is critical to provide clinical guidance and risk reduction strategie
Externí odkaz:
https://doaj.org/article/5962c2a4fd4e4ddfbc5ddbc8d056500f
Autor:
Bonniface Oryokot, Andrew Kazibwe, David Kagimu, Abraham Ignatius Oluka, Darlius Kato, Yunus Miya, Michael Bernard Etukoit, Eleanor Namusoke-Magongo
Publikováno v:
Implementation Science Communications, Vol 4, Iss 1, Pp 1-12 (2023)
Abstract Background Retention in care and HIV viral load suppression remains sub-optimal among HIV positive adolescents in many settings including TASO Uganda, despite the implementation of interventions such as regimen optimization and community-bas
Externí odkaz:
https://doaj.org/article/4e107244b87342998470d46e3470d469
Autor:
Ronald Opito, Keneth Kwenya, Saadick Mugerwa Ssentongo, Mark Kizito, Susan Alwedo, Baker Bakashaba, Yunus Miya, Lameck Bukenya, Eddy Okwir, Lilian Angwech Onega, Andrew Kazibwe, Emmanuel Othieno, Fred Kirya, Peter Olupot Olupot
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0300916 (2024)
BackgroundTuberculosis (TB) is the leading cause of death among infectious agents globally. An estimated 10 million people are newly diagnosed and 1.5 million die of the disease annually. Uganda is among the 30 high TB-burdenedd countries, with Karam
Externí odkaz:
https://doaj.org/article/55568b867496437ca5a7a038d911cbc2
Autor:
Andrew Kazibwe, Kuteesa Ronald Bisaso, Andrew Peter Kyazze, Sandra Ninsiima, Phillip Ssekamatte, Felix Bongomin, Joseph Baruch Baluku, Davis Kibirige, George Patrick Akabwai, Moses R. Kamya, Harriet Mayanja-Kizza, Pauline Byakika-Kibwika, Magid Kagimu, Robert Kalyesubula, Irene Andia-Biraro
Publikováno v:
Tropical Medicine and Health, Vol 50, Iss 1, Pp 1-13 (2022)
Abstract Background The growing burden of diabetes mellitus (DM) and hypertension (HTN) on the background of endemic Human Immuno-deficiency Virus (HIV) and tuberculosis (TB) is a concern in low- and middle-income countries. We aimed to describe annu
Externí odkaz:
https://doaj.org/article/2fd2f0b9aa3e4032aaeaf69f6e9b3a8f
Autor:
Keith Twirire Kakame, Noel Namuhani, Andrew Kazibwe, Felix Bongomin, Joseph Baruch Baluku, Sebastian Olikira Baine
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The incidence of tuberculosis (TB) is high in Uganda; yet, TB case detection is low. The population-based survey on the prevalence of TB in Uganda revealed that only 16% of presumptive TB patients seeking care at health facilities
Externí odkaz:
https://doaj.org/article/37722817b7ae4554b5586774ed484f7d
Autor:
Andrew Kazibwe, Bonniface Oryokot, Levicatus Mugenyi, David Kagimu, Abraham Ignatius Oluka, Darlius Kato, Simple Ouma, Edmund Tayebwakushaba, Charles Odoi, Kizito Kakumba, Ronald Opito, Ceasar Godfrey Mafabi, Michael Ochwo, Robert Nkabala, Wilber Tusiimire, Agnes Kateeba Tusiime, Sarah Barbara Alinga, Yunus Miya, Michael Bernard Etukoit, Irene Andia Biraro, Bruce Kirenga
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0266285 (2022)
IntroductionIsoniazid preventive therapy (IPT) is effective in treating tuberculosis (TB) infection and hence limiting progression to active disease. However, the durability of protection, associated factors and cost-effectiveness of IPT remain uncer
Externí odkaz:
https://doaj.org/article/5e32ad0b2f6a409ca8e3fdc64194456a
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240374 (2020)
BackgroundChronic pulmonary aspergillosis (CPA) requires prolonged treatment with itraconazole or voriconazole. However, adverse events (AEs) are common with the use of these agents, with the need to discontinue the offending drug in a significant pr
Externí odkaz:
https://doaj.org/article/e7a8c31e490346e8b5fa51db631b7bdc
Autor:
Andrew Kazibwe, Bonniface Oryokot, Andrew Peter Kyazze, Philip Ssekamatte, George Patrick Akabwai, Emmanuel Seremba, David Mukunya, Magid Kagimu, Irene Andia-Biraro, Robert Kalyesubula
Publikováno v:
AIDS and Behavior.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beaf180d5875ee479529fa6509acfcf
https://doi.org/10.1007/s10461-023-04092-2
https://doi.org/10.1007/s10461-023-04092-2
Autor:
Bonniface Oryokot, Andrew Kazibwe, David Kagimu, Abraham Ignatius Oluka, Yunus Miya, Michael Bernard Etukoit, Eleanor Namusoke, Darlius Kato
Background Retention and HIV viral load suppression remains suboptimal among the adolescents living with HIV in many settings including TASO Uganda, despite the implementation of interventions such as regimen optimization and community-based approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2612c69a9cc9c761883c09e5fe2c8fa8
https://doi.org/10.21203/rs.3.rs-2464089/v1
https://doi.org/10.21203/rs.3.rs-2464089/v1
